AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis
Open Access
- 30 September 2005
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 12 (3), 413-421
- https://doi.org/10.1016/j.ymthe.2005.04.018
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Biodistribution of rAAV Vectors Following Intraocular Administration: Evidence for the Presence and Persistence of Vector DNA in the Optic Nerve and in the BrainMolecular Therapy, 2005
- Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosisNeurobiology of Disease, 2004
- Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosisNeurobiology of Disease, 2004
- AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII miceMolecular Therapy, 2004
- Genetics of the neuronal ceroid lipofuscinosesCurrent Opinion in Genetics & Development, 2000
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Novel Tools for Production and Purification of Recombinant Adenoassociated Virus VectorsHuman Gene Therapy, 1998
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Inborn Errors of Mucopolysaccharide MetabolismScience, 1970